05595721 is referenced by 116 patents and cites 5 patents.

Methods for the treatment of lymphoma by adminstration of a B cell-specific antibody are described. The invention encompasses providing to a patient both unlabeled antibodies and antibodies labeled with a radioisotope. A principal advantage of the method is that tumor responses can be obtained in a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy.

Title
Radioimmunotherapy of lymphoma using anti-CD20
Application Number
8/121582
Publication Number
5595721
Application Date
September 16, 1993
Publication Date
January 21, 1997
Inventor
Richard L Wahl
Ann Arbor
MI, US
Stephan D Glenn
Davie
FL, US
Gregory M Butchko
Miami Lakes
FL, US
Mark S Kaminski
Ann Arbor
MI, US
Assignee
Coulter Pharmaceutical
CA, US
IPC
A61K 51/10
View Original Source